Introduction
Peripartum cardiomyopathy (PPCM) is a life-threatening heart disease in women, characterized by a sudden onset of heart failure in the last month of pregnancy and in the first months after delivery, associated with a high morbidity and mortality. 1 -4 The major common diagnostic criteria are as follows: (i) a systolic dysfunction with an ejection fraction (EF) ,45% and (ii) no pre-existing heart disease except PPCM prior to peripartum heart failure. 4 Major co-morbidities are pregnancy-associated hypertensive disorders 5, 6 and inflammation as indicated by up-regulation of pro-inflammatory serum markers such as sFas/Apo1, C-reactive protein, interferon-g † M.R-H. and I.B. contributed equally to this work.
(IFNg), tumour necrosis factor-a (TNFa), and interleukin 6. 5, 7 More recent work suggests that many of these different disease-inducing factors merge in a common downstream mechanism, where enhanced oxidative stress plays a central role, which leads to the activation of the protease, cathepsin D (CD), and subsequent cleavage of prolactin (PRL) into an angiostatic and pro-apoptotic N-terminal 16 kDa PRL fragment (16 kDa PRL). The 16 kDa PRL causes massive endothelial damage and myocardial dysfunction, whereby a large part of the adverse effects of 16 kDa PRL seem to be mediated by microRNA-146a (miR-146a). 8 -11 In recent studies, increased endothelial microparticles and anti-angiogenic sFlt-1 have been reported in experimental models of PPCM and in PPCM patients, supporting the idea that angiogenic imbalance and endothelial damage play key roles in PPCM. 9, 12 Critical signalling pathways for protection of the maternal heart from peripartum stress involve the signal transducerand activatoroftranscription-3 (STAT3) and/orperoxisome proliferator-activated receptor gamma, coactivator-1 alpha (PGC-1a). 8 -11 Both factors are involved in defence from oxidative stress by up-regulation of anti-oxidative enzymes, such as manganese superoxide dismutase (MnSOD) and for pro-angiogenic stimuli, by up-regulation of vascular endothelial growth factor (VEGF). 8 -11 Observations from PPCM patients with subsequent pregnancies suggest that patients are protected throughout pregnancy from heart failure and that the disease re-emerges mainly in the peripartum phase. 4, 13 During pregnancy PI3K/Akt signalling is highly activated, in part by increased mechanical stress, but also by high levels of circulating pregnancy hormones such as oestrogens. 8, 14, 15 PI3K/Akt signalling promotes physiological hypertrophy and seems, at least in part, to be responsible for adaptation and protection of the maternal heart during pregnancy. After the delivery, mechanical stress and oestrogen levels decrease rapidly and postpartum PI3K/Akt signalling is no longer increased. 8 We investigated whether enhanced Akt activation in the postpartum maternal heart may compensate for loss of STAT3 and protect the maternal heart from PPCM. We therefore introduced a cardiomyocytespecific constitutively active Akt transgene (E40K-Akt) into our CKO PPCM mouse model. 16 In contrast to our expectation, the resulting CKO;CAkt tg mice displayed a higher postpartum mortality associated with even more hypertrophy, fibrosis, and inflammation, compared not only with wild type, but also with CKO or CAkt tg littermates.
However, the CAkt tg mice also developed a milder form of PPCM, with significantly reduced cardiac function and compromised cardiac vasculature. Molecular analyses revealed evidence for enhanced oxidative stress in both models at least in part caused by activation of p66 Src homology 2 domain containing protein (SHC) and impaired FoxO3A signalling. Furthermore, we found that PRL, full length as the cleaved 16 kDa form, is critically involved in the PPCM phenotype of both CAkt tg and CKO;CAkt tg mice since bromocriptine (BR) attenuated PPCM in both genotypes. Thus, our data show that activation of Akt in the postpartum period is detrimental because it reduces anti-oxidative defence. Furthermore, our data suggest that a combination of factors, such as IFNg and PRL, could promote an inflammatory type of PPCM by activating Akt signalling in the postpartum heart.
Methods
Cell culture media were obtained from Biochrome. IFNg was obtained from Immunotools and inhibitors from Calbiochem. The recombinant 16 kDa PRL was essentially produced as described previously. 8 BR (bromocriptinmesilat) was purchased from Novartis (Ulm, Germany) for in vivo use. All other chemicals were purchased from Sigma. ). Sibling females 10 -12 weeks of age were analysed at baseline, subjected to pregnancies, or kept as age-matched controls (nulli pari, NP).
Animal experiments
For chronic administration of PRL, osmotic minipumps (Alzet; PRL 400 iU/kg/day) were implanted in sedated mice and analysed after 14 days of chronic infusion. Adenoviruses, LacZ-Ad, or CD-Ad (3 × 10 8 pfu of each virus) were injected directly into the mouse left ventricle (LV) and analysed after 7 days, as previously described. 8 CKO;Akt tg and CAkt tg females were treated with BR (4 mg/kg/day, Novartis) in drinking water, 3 days before to 3 weeks after delivery, for two consecutive pregnancies. Echocardiography was performed, as described previously. 8, 17, 18 Mice were sacrificed and hearts were harvested. All animal studies were in accordance with the German animal protection law and with the European Communities Council Directive 86/609/EEC and 2010/63/EU for the protection of animals used for experimental purposes. All experiments were approved by the Local Institutional Animal Care and Research Advisory Committee and permitted by the local authority.
Cell culture experiments with cardiomyocytes
Isolation and cultivation of neonatal rat cardiomyocytes (NRCM) were performed, as described previously. 17, 18 Stimulation with IFNg (50 -1000 iU/mL, Immunotools) was carried out for 15 min on cardiomyocytes under serum-free conditions in DMEM/M199 (4:1). The Akt inhibitor LY294002 (10 mM) or the STAT3 inhibitor peptide (10 mM) was applied 1 h prior to stimulation with IFNg (100 iU/mL) or PRL (0.2 iU/mL). NRCM were stimulated with IFNg and/or PRL for 15 min or 24 h.
qRT-PCR, miR-qRT-PCR, and western blot
Total RNA isolation, real-time PCR, and expression of mature miR-146a (Applied BioSystems) were performed as described. 11, 18, 19 Protein expression levels were determined by western blotting, using SDS-PAGE as previously described. 17 More detailed information on the primer sequences and antibodies used are provided in the Supplementary material online, Methods.
Histology, immunostaining, and DNA damage quantification
Detailed description on histological analyses, immunohistochemistry, and DNA damage quantification (AP-sites assay, Abcam) is provided in the Supplementary material online, Methods.
Statistical analyses
Data are presented as mean + SD. Differences between groups were analysed by Mann-Whitney test, log-rank test, Student's t-test, or ANOVA, followed by Bonferroni as appropriate. A two-tailed P-value of ,0.05 was considered statistically significant.
Results
3. ), and WT (STAT3 fl/fl ) and the corresponding western blots from the LV tissue are shown in Figure 1A and B. We showed previously that cardiac function and morphology in NP CKO female mice is largely comparable with WT. 8 Female mice with cardiac-specific overexpression of a constitutively active Akt transgene (E40K-Akt: CAkt tg ) 16 displayed concentric hypertrophy with a preserved cardiac function and a slightly reduced heart rate at 3 and 6 months of age compared with WT ( Table 2) . Postpartum CKO, CAkt tg , and CKO; CAkt tg hearts were enlarged and dilated compared with WT, and heart weight (HW) and HW/body weight (BW) ratio, as well as CSA, were significantly higher in postpartum CAkt tg and CKO;CAkt tg compared with postpartum WT mice ( Figure 2B and C, Table 2 ). Due to different cardiomyocyte size of the mutant and WT mice, capillary density was determined per LV area. The capillary density was lower and the degree of fibrosis was higher in CKO, CAkt tg , and CKO;CAkt tg compared with WT hearts ( Figure 2D -G). The degree of inflammatory infiltrates, as indicated by positive staining for the pan-inflammatory marker CD45, was higher in CKO and CAkt tg hearts compared with WT and highest in CKO;CAkt tg mice ( Figure 2H and I ). Staining for macrophage marker MOMA2 and granulocyte marker Ly-6G + C indicated that numerous macrophages and granulocytes were present in postpartum hearts from CKO;CAkt tg mice ( Figure 2J ).
Evidence for increased oxidative stress and generation of the anti-angiogenic 16 kDa PRL in postpartum CAkt tg and CKO;CAkt tg
We previously reported that, in CKO mice with PPCM, the antioxidative MnSOD was reduced. 8 Here we observed that cardiac MnSOD mRNA expression is also reduced in postpartum CAkt tg (239 + 27%, P , 0.05 vs. WT-PP) and in postpartum CKO;CAkt tg mice (262 + 9%, P , 0.05 vs. WT-PP), suggesting increased oxidative stress in postpartum hearts of both genotypes ( Figure 3A) . It has been shown that oxidative stress activates p66SHC adaptor protein (SHC) in the cardiovascular system. 20 Moreover, Akt signalling can be modulated by activated SHC and, thereby, selectively phosphorylate with this inactivate FoxO3A, a known transcription factor that regulates MnSOD. 21 We observed increased phosphorylation of SHC and of Role of Akt in peripartum cardiomyopathy hearts tended to have more DNA damage as well ( Figure 3D ). We showed previously that enhanced oxidative stress in postpartum hearts of CKO mice leads to subsequent activation of CD. 8 While neither NP CAkt tg nor CKO;CAkt tg displayed increased expression of the pro-form and the activated form of CD, both genotypes exhibited increased levels of both forms postpartum when compared with WT ( Figure 3C , see Supplementary material online, Figure S1A ). Increased CD activity promotes cleavage of the nursing hormone PRL into the angiostatic N-terminal 16 kDa PRL form. 8 Beside CD, MMP3 is also able to cleave PRL in the 16 kDa PRL. 22 We observed substantially higher levels of the pro-form and the active form of MMP3 ( Figure 3E , pro-form: three-to five-fold, active form: two-fold, P , 0.05 vs. postpartum WT) in postpartum CKO;CAkt tg mice, while postpartum CAkt tg displayed no such increase ( Figure 3E ). In addition, we found that PRL moderately induces MMP3 in neonatal rat cardiac fibroblasts (NRCF) and in NRCM, and 16 kDa PRL markedly induces MMP3 expression in NRCF but not in NRCM (see Supplementary material online, Figure S2A -D). We showed that 16 kDa PRL promotes the up-regulation of microRNA-146a in postpartum hearts of CKO mice, a feature that is largely responsible for PPCM in these mice. 11 Increased miR-146a levels were present in LV tissue of postpartum CAkt tg and CKO;CAkt tg mice compared with WT mice ( Figure 3F ). Monocyte chemoattractant protein-1 (CCL2) is a major chemotactic factor for monocytes and a key factor for initiating the inflammatory process. It is up-regulated by full-length PRL in macrophages 23 and by 16 kDa PRL in endothelial cells. 24 We observed that CCL2 protein levels are substantially higher in hearts of postpartum CKO;CAkt tg mice compared with all other genotypes ( Figure 3G ). We previously reported that blocking PRL by BR prevented onset of PPCM in CKO mice. 8 Similar to the effect in CKO mice, BR provided shortly before delivery and for the first 3 weeks following the delivery, prevented the high postpartum mortality in CKO;CAkt tg mice ( Figure 4A ). In addition, it attenuated heart failure and LV dilatation in both CAkt tg and CKO;CAkt tg mice ( Table 2) . BR-treated CKO;CAkt tg mice, but not CAkt tg , displayed lowered HW/BW ratio and reduced CSA in comparison with females not treated ( Table 2) . Cardiac fibrosis was significantly reduced and capillary density increased in BR-treated CAkt tg and in CKO;CAkt tg mice ( Figure 4B and C). BR treatment also reduced the degree of inflammatory infiltrates ( Figure 4D ), CCL2 mRNA (237 + 14%. P , 0.05 vs. not treated CKO;CAkt tg ), and protein levels in CKO;CAkt tg mice ( Figure 4E) . Furthermore, miR-146a level were markedly lower in BR-treated postpartum CKO;CAkt tg mice ( Figure 4F ).
PRL promotes inflammation in CKO;CAkt tg mice independent of pregnancy
To evaluate whether PRL per se is able to evoke different inflammatory responses in hearts of WT, CKO, CAkt tg , and CKO;CAkt tg mice, we infused all four genotypes with recombinant sheep PRL (400 iU/kg/day) or saline, using osmotic minipumps for 2 weeks. While control saline infusion had no effect on cardiac inflammation in all four genotypes, PRL infusion increased CD45-positive inflammatory infiltrates ( Figure 5A -C ) and expression of CCL2 (see Supplementary material online, Figure  S3 of recombinant PRL, in WT mice promoted cardiac inflammation, indicating that 16 kDa PRL promotes cardiac inflammation ( Figure 5D ).
In cardiomyocytes IFNg and PRL induce activation of CCL2 via Akt signalling, a feature that is potentiated by the combination of the two factors
We showed previously that elevated markers for inflammation are present in almost all African PPCM patients and that, in these patients, high serum levels of IFNg, PRL, and oxLDL correlate with an adverse outcome in PPCM. 7 To investigate a mechanistic connection between these three factors for cardiac inflammation, we stimulated NRCM in culture with IFNg and/or recombinant PRL. As shown in Figure 5E , IFNg induced activation of Akt, STAT1, and STAT3. PRL induced activation of STAT1, STAT5, and Akt but not of STAT3 in NRCM ( Figure 5F ). IFNg and PRL induced the expression of CCL2 mRNA in NRCM, an effect that was potentiated by the combination of the two factors ( Figure 5G ). Pharmacological inhibition of Akt with LY 294002 reduced CCL2 mRNA expression in NRCM stimulated with IFNg, PRL, or IFNg and PRL ( Figure 5G ). Pharmacological inhibition of STAT3 with the STAT3 inhibitor peptide had no significant effect on IFNg-mediated induction of CCL2 expression in NRCM ( Figure 5H ).
Discussion
The maternal heart needs strong protection against stress factors induced by physiological and pathophysiological stimuli during pregnancy, delivery, and the early postpartum phase. It is assumed that the Role of Akt in peripartum cardiomyopathy PI3K/Akt signalling pathway activated by oestrogens and potentially also by increased mechanical stimuli (i.e. increased volume load of the heart during pregnancy) plays an important role in cardioprotection during pregnancy. 15 The decrease in Akt activation in the postpartum maternal heart 8,15 is likely a consequence of the rapid decline in circulating oestrogens and the unloading of the heart after delivery. In turn, STAT3 and PGC-1a appear to be factors specifically needed in the peripartum phase to protect the maternal heart from enhanced oxidative stress and circulating anti-angiogenic factors by up-regulating anti-oxidative enzymes, such as MnSOD, and pro-angiogenic factors, such as VEGF. 8, 9, 11 Here we evaluated whether enhanced activation of Akt in cardiomyocytes may compensate for loss of STAT3 activation in the peripartum heart, with the idea that activation of this pathway may be an additional therapeutic option in this disease. However, our data clearly show that this is not the case, as Akt activation under reduced STAT3 conditions accelerates peripartum heart failure and mortality as observed in CKO;CAkt tg mice. Moreover, even peripartum activation of Akt with intact cardiac STAT3 signalling leads to PPCM with enhanced hypertrophy and reduced cardiac function. Similar to our observations in CKO and in PGC-1a knockout mice, 8, 9 we noted increased activation of p66SHC and reduced expression of MnSOD in postpartum hearts from CKO;CAkt tg and CAkt tg mice, suggesting enhanced oxidative stress, a feature that was further confirmed by increased DNA damage. In line with reduced anti-oxidative capacity, because of lower MnSOD expression, we found enhanced levels of activated CD, a protease known to be activated in the heart by oxidative stress and which, upon activation, efficiently cleaves PRL into its anti-angiogenic 16 kDa form. 8 We have described previously MMP3 as the MMP whose expression is increased in CKO mice with PPCM. 8 In addition, MMP3 is known to promote dilated cardiomyopathy and is able to activate other MMPs. 25, 26 Finally, MMP3 is able to cleave PRL in its 16 kDa form. 22 We observed that the active and inactive forms of MMP3 are substantially up-regulated in CKO;CAkt tg mice, but not WT or CAkt tg mice. Full-length PRL and/or 16 kDa PRL are inducing MMP3 expression in cardiac fibroblasts and in cardiomyocytes suggesting a positive feedback loop for MMP3 expression and generation of 16 kDa PRL in CKO;-CAkt tg , which may contribute to the more severe form of PPCM in this genotype compared with CAkt tg . We also showed that 16 kDa PRL induces the expression of miR-146a, which mediates most of the adverse effects of 16 kDa PRL in PPCM. 11 The findings that miR-146a levels were increased in postpartum hearts from CKO;CAkt tg and CAkt tg mice and the fact that BR treatment attenuated PPCM in both genotypes supports the idea that enhanced oxidative stress, PRL cleavage, and the 16 kDa PRL are disease causing in these two novel mouse models of PPCM ( Figure 6 ). Thus, it seems that the deregulation of multiple up-stream signalling pathways, i.e. STAT3 or PGC-1a 8, 9 and/or Akt merge in a common pathway where the generation of 16 kDa PRL appears to be the common link ( Figure 6 ). With regard to the anti-oxidative capacity, we showed that MnSOD is crucial for cardioprotecion from enhanced peripartum oxidative stress, as mice hemizygote for MnSOD developed PPCM, MnSOD is reduced in postpartum CKO mice, and treatment of CKO mice with the MnSOD mimeticum MnTBAP protected partially them from PPCM. 8 Here we found that MnSOD expression was reduced in hearts from CAkt tg mice, suggesting that activation of Akt in the peripartum heart is suppressing the expression of this gene. The combination of both STAT3 deficiency in CKO;CAkt tg mice did not further accelerate the decrease of MnSOD expression, suggesting that both pathways may merge in the regulation of a common transcription factor. In this regard, it is known that the transcription factor FoxO3A regulates the expression of MnSOD. 27 FoxO3A becomes active by de-phosphorylation and translocates to the nucleus, a feature that is promoted by activated STAT3. 28 In turn, Akt signalling modulated by the p66SHC adaptor protein (SHC) can selectively phosphorylate and, with this, inactivate FoxO3A, which subsequently leads to a down-regulation of MnSOD. 21 This specific Akt signalling pathway does not regulate GSK3. 21 Here we observed that SHC and FoxO3A phosphorylation were higher in postpartum hearts form CKO, CAkt tg , and CKO;CAkt tg mice compared with WT.
In addition, activation of p66SHC is of even broader importance for the regulation of the intracellular redox balance as in addition to its negative regulation of MnSOD, it triggers NADPH membrane oxidase-induced ROS production and it migrates to the mitochondrial intermembrane space where it promotes the production of H 2 O 2 .
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These data suggest that STAT3 and Akt play opposing roles in the postpartum heart with regard to a circuit involving p66SHC and FoxO3A, subsequent regulation of MnSOD, and protection from oxidative stress ( Figure 6 ). We observed a substantially higher increase in the HW/BW ratio and in CSA, together with a rarification of capillaries in postpartum CAkt tg mice, a feature that was even more pronounced in CKO;CAkt tg mice.
This feature was paralleled by a decrease in cardiac function which was more severe in CKO;CAkt tg mice. BR treatment prevented cardiac dysfunction and increased the cardiac capillary density without substantially affecting the degree of hypertrophy in CAkt tg mice.
These data suggest that the pregnancy-induced cardiac hypertrophy is more pronounced and potentially less reversible in CAkt tg , compared with WT mice. The observation that BR treatment is not able to reverse peripartum hypertrophy in the CAkt tg mice suggests that this effect is independent of PRL. In turn, the positive effect of BR on peripartum CAkt tg , which is associated with increased capillary density, suggest that diminished vasculature most likely caused by the 16 kDa PRL form is causal for PPCM in this genotype. BR treatment prevented cardiac dysfunction and the decrease in the cardiac vasculature in CKO;CAkt tg , suggesting that 16 kDa PRL-mediated pathophysiological effects are also involved in PPCM of this genotype. However, BR treatment also attenuated the massive cardiac hypertrophy and inflammation in the postpartum CKO;CAkt tg hearts. Cardiac inflammation can induce cardiac oedema and cardiomyocyte swelling which, subsequently, impairs cardiac function. 29 Treatment with BR attenuated cardiac inflammation and may, therefore, also prevent oedema and cardiomyocyte swelling, a notion that could explain why the increase in HW/ BW and CSA was blunted in BR-treated CKO;CAkt tg . The combination of low STAT3 and high Akt conditions promotes cardiac inflammation in the postpartum heart, which was associated with an increased expression of CCL2, a chemokine known to attract inflammatory cells, mainly macrophages. 30 It was not possible for us to distinguish, in the postpartum CKO;CAkt tg hearts, whether CCL2 has primarily been secreted by the stressed cardiomyocytes or whether it is released by the invading inflammatory cells. However, it is likely to be connected with the high levels of circulating PRL in the postpartum phase, since we showed that infusion of PRL alone was able to increase inflammatory infiltrates in CKO;CAkt tg hearts, compared with the other three genotypes. In addition, we also showed that the generation of 16 kDa PRL by overexpression of activated CD and infusion of PRL in the heart of WT mice was sufficient to induce cardiac inflammation. While we could not convincingly show that 16 kDa PRL induces CCL2 in cardiomyocytes, it had been shown previously that 16 kDa PRL induces CCL2 expression in endothelial cells, 24 a feature that may M. Ricke-Hoch et al.
also contribute to cardiac inflammation in postpartum CKO;CAkt tg mice. In an African PPCM collective we have previously observed that higher PRL levels and oxLDL (a marker for oxidative stress) correlated with the failure to cease inflammation, a feature, which predicted poor outcome. 7 In cultured cardiomyocytes, we found that full-length PRL induces Akt, STAT1, and STAT5 activation while STAT3 was not significantly induced. Moreover, PRL induced CCL2 expression in cardiomyocytes, which could be prevented by pharmacological inhibition of Akt. A third factor that correlated with inflammation and poor outcome in this African collective was IFNg. 7 We observed that IFNg induced STAT1, STAT3, and Akt activation and increased the expression of CCL2, a feature that was previously shown by others. 31 The IFNg-mediated increase in CCL2 expression could completely be blocked by pharmacological inhibition of Akt, while blocking STAT3 had no effect. To mimic the situation in the African patients, we co-stimulated the cardiomycytes with PRL and IFNg and observed cumulative effects of both factors for the induction of CCL2, which could be attenuated by pharmacological inhibition of Akt. A possible explanation for these findings could be that both PRL and IFNg induce CCL2 but via different signalling pathways ( Figure 6 ). The precise mechanism needs to be clarified in future experiments.
In conclusion, our data suggest that enhanced Akt signalling in postpartum hearts is not protective and, in fact, is disease promoting. Furthermore, the present study indicates that deregulation of multiple up-stream factors such as STAT3 or PGC-1a 8, 9 or, as shown here, Akt, in the postpartum heart merge in a common pathway involving a shift in the redox balance towards increased oxidative stress and subsequent generation of 16 kDa PRL that impairs the cardiac vasculature, which finally is leading to PPCM ( Figure 6 ). In addition, postpartum Akt activation in situations predisposed to develop PPCM due to lower STAT3 activation appears to be even more detrimental since it promotes cardiac inflammation, as observed in postpartum CKO;CAkt tg mice. Finally, this study is in line with previous experimental data 8, 9, 11 showing that PRL blockade with BR is able to prevent PPCM in female mice at risk for the disease. A high risk to develop PPCM is also present in PPCM patients with a subsequent pregnancy. 13 Data from a small collective of PPCM patients with subsequent pregnancies suggests that BR may prevent the relapse of the disease. 8 In addition, the beneficial effect of BR in meanwhile four different experimental models of PPCM, CKO, 8 PGC-1a knockout, 9 CAkt tg , and CKO;CAkt tg supports the notion that, albeit different aetiologies for the disease are likely, eliminating the common culprit factor PRL, full-length and 16 kDa PRL, seems to be efficient in a broad range of PPCM forms. In line with this idea are a pilot study, case reports and data from the German PPCM registry where BR treatment is, in general, associated with a better recovery and outcome in a highly heterogeneous collective of PPCM patients. 5, 8, 10, 32 However, it is necessary to test the BR therapy concept in larger controlled randomized multicentre trials as the one that we are currently performing in Germany (randomization of 60 PPCM patients to BR-therapy or no BR-therapy, study registered at ClinicalTrials.gov, study number: NCT00998556). Role of Akt in peripartum cardiomyopathy
